| Literature DB >> 27798914 |
Miroslava Sarlinova1, Mirko Halasa2,3, Dusan Mistuna3,4, Ludovit Musak5, Robert Iliev6, Ondrej Slaby6, Jana Mazuchova7, Vanda Valentova8, Lukas Plank9, Erika Halasova10,8.
Abstract
The Aim of this study was to evaluate the expression levels of miR-21, miR-221, miR-150, let-7a and miR-126a in peripheral blood of 71 patients with colorectal cancer and 80 matched healthy control individuals. We determined expression levels of these microRNAs in peripheral blood samples and used small nucleolar RNA (RNU48) as an internal control. Expression levels of miR-21 (p<0.0001) and miR-221 (p<0.0001) were significantly higher, whereas expression levels of miR-150 (p=0.0054) were significantly lower in the blood samples of patients with colorectal cancer in comparison to the control group. The combination of these three microRNAs enabled us to distinguish patients with colorectal cancer from healthy donors with a sensitivity of 80% and specificity of 74% (p<0.0001). We did not observe any correlation of the studied microRNAs with clinicopathological features of colorectal cancer, indicating that expression of these microRNAs is more likely related to the host response to the tumour than the tumour itself. CopyrightEntities:
Keywords: Colorectal cancer; biomarker; miRNA expression; microRNAs
Mesh:
Substances:
Year: 2016 PMID: 27798914 DOI: 10.21873/anticanres.11124
Source DB: PubMed Journal: Anticancer Res ISSN: 0250-7005 Impact factor: 2.480